This inventor holds 4 USPTO granted patents. Top assignees: Fujisawa Pharmaceutical Company, Ltd., Astellas Pharma Gmbh. Active years: 1987-2006.
Location History:
- Ikeda, JP (1987 - 1991)
- Itami, JP (2003 - 2006)
Company Filing History:
Years Active: 1987-2006
Title: Hiroshi Ishikuro: Innovator in Pharmaceutical Chemistry
Introduction
Hiroshi Ishikuro is a notable inventor based in Itami, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of stable forms of bradykinin antagonists. With a total of 4 patents to his name, Ishikuro's work has implications for the production of high-quality medicinal products.
Latest Patents
One of Ishikuro's latest patents is for a vitreous form of a known bradykinin antagonist. This invention relates to a vitreous form of 8-[3-[N-[(E)-3-(6-acetamidopyridin-3-yl)acryloylglycyl]-N-methylamino]-2,6-dichlorobenzyloxy]-2-methylquinoline (FR173657). This vitreous form exhibits good solid stability, making it useful for producing and supplying FR173657 products that maintain a stable quality suitable for medicinal use. Another patent also focuses on the vitreous form of the compound FR 173657, emphasizing its solid stability and suitability for medicine.
Career Highlights
Ishikuro has worked with prominent companies in the pharmaceutical industry, including Fujisawa Pharmaceutical Company, Ltd. and Astellas Pharma GmbH. His experience in these organizations has allowed him to refine his expertise in drug formulation and stability.
Collaborations
Ishikuro has collaborated with notable colleagues such as Yoshio Ueda and Norio Ohnishi. Their combined efforts have contributed to advancements in pharmaceutical innovations.
Conclusion
Hiroshi Ishikuro's work in developing stable forms of bradykinin antagonists showcases his innovative spirit and dedication to improving medicinal products. His contributions continue to influence the pharmaceutical industry positively.